Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting
Authors:
- Fabio MangiacapraFabio Mangiacapra
- Aaron PeaceAPAaron Peace
- Faisal SharifFSFaisal Sharif
- Micaela ConteMCMicaela Conte
- Jozef BartunekJBJozef Bartunek
- Marc VanderheydenMVMarc Vanderheyden
- William WijnsWWWilliam Wijns
- Bernard de BruyneBBBernard de Bruyne
- Emanuele BarbatoEBEmanuele Barbato
- 1 November 2011
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 162 (5) , 907-913
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- 2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily PracticeJACC, 2011
- Randomized Comparison of Everolimus- and Paclitaxel-Eluting StentsJACC, 2011
- Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting StentsJACC: Cardiovascular Interventions, 2010
- Safety and Efficacy Update on First-Generation Drug-Eluting StentsThe American Journal of Cardiology, 2008
- Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)European Heart Journal, 2007
- Relationship between angiographic late loss and target lesion revascularization after coronary stent implantationJACC, 2005
- Meta-analysis comparing drug-eluting stents with bare metal stentsThe American Journal of Cardiology, 2005
- Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trialsEuropean Heart Journal, 2005
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosisJACC, 1991